LSTM and HERD International PhD Fellowship Opportunity
Grants and Funding OpportunitiesInternational Jobs & OpportunitiesPhDPublic Health OpportunitiesPublic Health Opportunity

LSTM and HERD International PhD Fellowship Opportunity

by Public Health Update
written by Public Health Update

Overview

HERD International invites applications from Nepali citizens who have a Master’s degree or equivalent and a strong commitment to a three-year PhD program to join an exciting fellowship opportunity for a fully-funded program in collaboration with the prestigious Liverpool School of Tropical Medicine (LSTM).

492859532 690615676867770 5781075758676819655 n

Organization

HERD International is a research and development agency dedicated to generating and utilizing evidence to improve the health and well-being of people. It’s mission involves empowering individuals and communities through collaborative efforts with policy practitioners, researchers, and concerned stakeholders. HERD International, collaborates with national and global partners to strengthen systems and empower communities through inclusive, locally tailored solutions.

Project

Resilient and Equitable Health Workforce to Address Climate Threats (REACT) project, funded by the National Institute for Health and Care Research (NIHR), UK, aligns with organization mission to enhance health workforce responsiveness to climate-related challenges in Nepal. This four-year (2025-2028) research project, funded by National Institute for Health and Care Research (NIHR), UK, is a collaborative effort between the Liverpool School of Tropical Medicine (LSTM), UK, the Center for Sexual Health, HIV & AIDS Research (CeSHHAR), Zimbabwe and HERD International, Nepal.

PhD Opportunity

Through the REACT project, HERD International fosters innovative research and offers two PhD fellowships in collaboration with the Liverpool School of Tropical Medicine (LSTM), enabling fellows to explore critical topics like decentralized governance and climate justice, contributing to resilient health systems and equitable outcomes for vulnerable communities.

Features of PhD Fellowships

  • Two candidates for the Fellowship.
  • Fellowship linked to a 3-year PhD program.
  • Fellows will be based at HERD International.
  • Collaboration with the LSTM, which is the awarding body for the PhD.
  • Fellows will be co-supervised by a team of LSTM and HERD International.

Fellowship Areas

Fellows will conduct research within the REACT project framework. Two research areas have been proposed.

  • Decentralized governance and climate resilience in the health sector – exploring the context, opportunities and challenges.
  • Climate justice and health equity: assessing the impact of climate change on health workforce and communities.

Applicants may select one of the above areas.

Eligibility Criteria:

  • Nepali citizen
  • Master’s degree or equivalent
  • Commitment to a three-year PhD program

Benefits: (for 2 candidates)

  • Full coverage of PhD fees.
  • Monthly stipend to support fellows during the program.
  • Research support costs according to project norms.
  • Access to LSTM’s academic resources and supervision.
  • Networking opportunities and
  • More

Location: Central Office, Bhaisepati, Lalitpur

Duration: This immersive, three-year fellowship will run from 2025, to 2028. Planned start date is 1 June 2025.

Required documents for application

Kindly note that, besides personal information, you need to submit the following documents (in PDF format) via an online application form:

  • Curriculum Vitae (max 3 pages)
  • Personal Statement (maximum 600 words) Addressing
    • Which research topic have you chosen and why?
    • What motivates you to apply to this program?
    • Why do you want to study at LSTM?
    • What do you hope to gain from this PhD program?
    • How does this fellowship align with your career plans?
    • What skills and/or experience would you bring to the PhD community?
    • What long-term benefits do you envisage for the REACT consortium?
  • A research proposal (maximum 1500 words) under the following headings:
    • Project Title
    • Abstract
    • Research Context and background
    • Specific Research Question(s)
    • Research Methods
    • Approximate research costs
    • Bibliography
  • Two References

Selection process:

  • Applications will be reviewed by fellowship selection committee.
  • Shortlisted candidates will proceed to an assessment / interview / presentation phase, conducted in person (preferred) or via virtual.
  • The selection process involves one or multiple interview rounds to assess competency, and suitability for the program.

Note:

  • Incomplete or incorrect applications may be rejected.
  • Application should be submitted using the provided online link.
  • One candidate can submit only one application.
  • Submitted application documents cannot be returned or changed.
  • Fellows will work in coordination with project team.
  • Personal information will be managed confidently and used for the selection of suitable and competent candidates.
  • Intellectual property related matters will be handled in accordance with HERD International regulations.

Instructions for applying:

  • Inquiry by: 30th April 2025, 5 PM NST at [applications @herdint.com].
  • Interested and qualified individuals are requested to use the below link for the application to be completed by May 7, 2025.

Online Application Form ↗↗

Fill out the online application form

Only short-listed candidates will be invited to participate in an assessment process. Any effort to influence the selection process will result in disqualification.

HERD International has the right to select candidates for the PhD fellowship in accordance with its policies and procedures, ensuring a fair and merit-based process.

Official Information & PhD Hand book: HERD INTERNATIONAL↗↗

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
World Malaria Day
Global Health NewsPH Important DayPublic Health UpdateVector-Borne Diseases(VBDs)

World Malaria Day 2025: Malaria Ends with Us: Reinvest, Reimagine, Reignite

by Public Health Update
written by Public Health Update

Overview

The World Malaria Day is observed annually on 25 April to highlight the critical need for continued investment and sustained political commitment in the prevention and control of malaria. This global observance was established by the Member States of the World Health Organization during the World Health Assembly in 2007, with the aim of raising awareness and mobilizing action to combat malaria worldwide.

World Malaria Day 2025: Malaria Ends with Us: Reinvest, Reimagine, Reignite

This year, the World Health Organization (WHO), in collaboration with the RBM Partnership to End Malaria and other stakeholders, is supporting the campaign “Malaria Ends With Us: Reinvest, Reimagine, Reignite.” This grassroots initiative seeks to revitalize efforts across all levels—ranging from global policymaking to local community engagement—to accelerate progress toward the goal of malaria elimination.

Campaign

  • Re-energize support: Re-energize efforts at all levels, from global policy to community action, to accelerate progress towards malaria elimination.
  • Sustain investment: Advocate for increased investment in malaria control and elimination programmes, including through successful replenishments for the Global Fund and Gavi, the Vaccine Alliance in 2025.
  • Promote innovation: Promote innovative strategies and approaches to tackle evolving challenges in malaria.
  • Engage communities: Prioritize country ownership, actively engage communities, and implement data-driven strategies.

Key messages

Reinvest:

Major public health problem

  • Despite significant progress, malaria remains a major public health problem, particularly in sub-Saharan Africa where an estimated one person dies of the disease every minute.
  • In 2023, there were an estimated 263 million new malaria cases in 83 countries worldwide, up from 252 million in 2022 and 226 million in 2015.
  • The global tally of malaria deaths reached 597 000 in 2023 compared to 578 000 in 2015.

Challenges

  • In many areas, challenges posed by extreme weather events, conflict and violence, and other global crises have disrupted malaria control efforts and threaten to reverse decades of achievements in global malaria control.

Funding gap

  • A substantial funding gap is further hindering the implementation of effective interventions and the development of new tools. In 2023 alone, total investments in malaria control reached US$ 4 billion, falling far short of the US$ 8.3 billion funding target of the WHO Global technical strategy for malaria 2016-2023.
  • The 2025 U.S. funding cuts are compounding an already critical situation – particularly for national malaria programmes in Africa. By mid-March, countries were reporting major disruptions in the delivery of essential health services for the prevention, diagnosis and treatment of many diseases, including malaria strategy

Successful replenishments

  • The successful replenishments of The Global Fund and Gavi, the Vaccine Alliance in 2025 are critical to financing malaria programmes and interventions, and accelerating progress towards the malaria control and elimination targets set in the WHO global malaria strategy.

 Call to Action

  • Increase funding for malaria elimination and control: Governments, donors, and the private sector must step up their financial commitments.
  • Support the full replenishment of the Global Fund and Gavi: ensure sustained resources for malaria programmes and interventions.
  • Boost domestic financing: ensure the long-term sustainability of malaria programmes through increased investment in malaria-affected countries.
  • Invest in proven interventions: prioritize investments in WHO-recommended tools such as insecticide-treated nets, indoor residual spraying, chemoprevention, malaria vaccines and artemisinin-based combination therapies (ACTs).
  • Build strong health systems: improve access to malaria prevention, diagnosis, and treatment services, especially for people most at risk

 Reimagine:

  • Innovative strategies and tools are needed to accelerate progress towards ending malaria

Drug resistance

  • Malaria parasites are developing resistance to antimalarial drugs, threatening the effectiveness of treatment.

Insecticide resistance

  • Mosquitoes are becoming resistant to insecticides, reducing the impact of primary vector control interventions.

 Climate change

  • Climate change is altering mosquito habitats and transmission patterns, posing new challenges for malaria control.

 Innovative strategies and tools

  • Innovative strategies and tools are needed to overcome these challenges and to accelerate progress towards elimination.

 Call to Action

  • Use data-driven strategies to drive impact: tailor malaria interventions to local contexts through evidence-based, data-driven strategies.
  • Accelerate innovation: invest in research and development to discover new and more effective antimalarial drugs, diagnostics, insecticides, vaccines and vector control methods.
  • Unlock new funding solutions: explore and implement innovative financing mechanisms to bridge resource gaps for malaria control.
  • Turn research into action: foster collaboration between researchers, policymakers, and programme implementers to rapidly translate research findings into real-world impact.

Reignite:

  • It’s time to renew the commitment to ending malaria 

Complacency and fatigue

  • can undermine efforts to control and eliminate malaria.

Political will and community engagement are essential to sustain progress.

  • A renewed sense of urgency and commitment is needed to accelerate the fight against malaria.

Call to Action

Join the Big Push to end malaria: Now is the time for the malaria community to unite and turn commitments into action. The Big Push against malaria is a multistakeholder effort to drive progress through 6 priority actions:

  1. Improve coordination between global, regional, and country partners
  2. Uphold national leadership and accountability while advancing an inclusive, whole-of-society approach
  3. Strengthen data systems and enable data-driven decision-making
  4. Increase the accessibility, acceptability and quality of existing interventions
  5. Develop and prepare for the rapid introduction of new, transformational tools
  6. Increase funding for malaria, building on a new narrative

The Big Push responds to country-driven initiatives such as the Yaoundé Declaration and the Lusaka Agenda.

Step up political and financial commitments: The RBM Partnership and WHO call for shared responsibility to protect the hard-won gains against malaria—especially in this time of global instability. Malaria-endemic countries must lead with strong political commitment and domestic investment, backed by sustained funding from their global partners.

Celebrate success, inspire action: The malaria community must celebrate its successes and share lessons learned to encourage everyone to take action to end malaria.

 Strengthen community action: Equip people with the information and resources they need to prevent, detect, and treat malaria effectively.

Learn more: WHO website  ↗

Related readings

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
World Immunization Week 2025: Immunization for All is Humanly Possible
ActivitiesPH Important DayPublic HealthPublic Health UpdateVaccine Preventable Diseases

World Immunization Week 2025: Immunization for All is Humanly Possible

by Public Health Update
written by Public Health Update

Overview

Each year, World Immunization Week is observed in the last week of April with the aim of highlighting the collective action needed and promoting the use of vaccines to protect people of all ages against disease. This year, World Immunization Week 2025 will be celebrated from 24 to 30 April with the slogan “Immunization for All is Humanly Possible.

Vaccines are one of humanity’s greatest achievements.

In the last 50 years alone, vaccines have saved almost 154 million lives. That’s six people, every minute, for five decades. Nearly 94 million of the lives saved were a result of measles vaccines.

Decades of collaborative efforts between governments, aid agencies, scientists, healthcare workers, and parents got us to where we are today – a world where we’ve eradicated smallpox and almost eradicated polio; a world where more children than ever before in history live to see their fifth birthday.

Immunization Agenda 2030: A global strategy to leave no one behind

In 2025, we are at a watershed moment in the history of global health. Hard-won gains in immunization are in jeopardy. To protect humanity’s greatest achievement, we must be fierce in our determination to reach all children with essential vaccines, and intensify our efforts to ensure people of all ages are protected from vaccine- preventable disease – grandparents against influenza, pregnant mothers against tetanus, and young girls against HPV.

Campaign Aim

Humanly Possible calls on:

  1. Parents and communities to vaccinate themselves and their children;
  2. Governments to invest in strengthening immunization services at local and national levels
    to ensure all children are protected;
  3. Health workers to promote the power of immunizations.
Key Messages

Immunization is one of humanity’s greatest achievements.

  • In the last 50 years alone, vaccines have saved 154 million people – that’s more than 3 million a year or 6 people every minute. An estimated 94 million of these lives saved were a result of protection by measles vaccines.
  • In the same period, vaccination accounts for 40% of the improvement in infant survival, meaning more children now live to see their first birthday.
  • Even more people of all ages are being protected against vaccine-preventable diseases every day.
  • Immunization reaches more people than any other health service, connecting families with health care systems and helping everyone have access to the care they need.

Vaccines for one person also keep other people safe.

  • In today’s interconnected world, an outbreak anywhere is a threat everywhere.
  • By supporting vaccinations, we are not just saving lives, but keeping deadly outbreaks from diseases such as measles, diphtheria, cholera, in check all over the world.
  • Responding to outbreak after outbreak is an expensive and ineffective way to fight disease, and needlessly puts lives at risk.
  • A sustainable way to stop this cycle is through prevention – ensuring people everywhere are protected with the right vaccines, at the right time, from birth into old age.
  • It is important to get vaccinated on time, every time. Waiting until there is an outbreak is too late.
  • There may not be enough time to receive all the vaccine doses needed to keep you and your family safe from the disease. You or your loved ones may be the ones who are part of the outbreak.

Vaccines ensure less disease and more life.

  • Vaccines save lives at all ages – protecting us throughout childhood and adulthood from upwards of 30 infections and deadly diseases.
  • Since 1988, 3 billion children have been immunized against polio and 20 million people are walking today who would have otherwise been paralyzed by polio.
  • Vaccines create futures. A fully vaccinated child is more likely to become healthy enough to learn, grow and contribute to their community in a way that unhealthy children can’t always do.
  • In a time of competing priorities, vaccines are one of the best investment choices governments can make to keep their people healthy and safe. By continuing to invest in vaccines, we can help build a world where fewer children than ever die of preventable diseases.

Not everyone has the same access to life-saving vaccines.

  • The world has made incredible gains to improve global immunization access, but progress has stalled in recent years and millions of children are not getting the vaccinations they desperately need.
  • In 2023, an estimated 14.5 million children never received a single dose of any vaccine. Despite the measles vaccine saving more lives than any other vaccine in the past five decades, more than 22 million children still missed out on their first dose of this vaccine and another 12 million missed out on their second dose in 2023.
  • Every child has the right to be protected from vaccine-preventable diseases – no matter who they are or where they live.
  • Increasing access to vaccines everywhere is the best way to give every child a healthy start to life and protect them against preventable diseases from birth into old age.

Immunization for all is Humanly Possible.

  • We are at a watershed moment in the history of global health. Hard-won gains in stamping out diseases that are preventable through vaccination are in jeopardy. Decades of collaborative efforts between governments, aid agencies, scientists, healthcare workers, and parents got us to where we are today – a world where we’ve eradicated smallpox and almost eradicated polio.
  • In this critical moment, we cannot afford to blink. To protect humanity’s greatest achievement, we must be fierce in our determination to reach all children with essential vaccines, and intensify our efforts to ensure people of all ages are protected from vaccine-preventable disease – grandparents against influenza, pregnant mothers against tetanus, and young girls against HPV.
  • New vaccine development and introductions, including the malaria vaccine for children and potential TB vaccines for adolescents and adults, are also essential to advance our fight against some of the world’s most stubborn diseases and help the world prepare for health threats we’ve yet to encounter but know are out there.
  • To ensure that the successes of the past 50 years are built on over the next decades, new investments are needed.
  • That’s why we’re calling on governments to prioritize investments in immunization, including funding Gavi, the Vaccine Alliance and other key programmes, to protect the next generations.

Learn more: WHO website ↗ Gavi’s VaccinesWork platform ↗ UNICEF ↗

Recommended readings
0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Call for Applications- Fully funded two-year postdoctoral position
Grants and Funding OpportunitiesInternational Jobs & OpportunitiesPostDocPublic Health OpportunitiesPublic Health Opportunity

Call for Applications- Fully funded two-year postdoctoral position

by Public Health Update
written by Public Health Update

The NIHR Global Health Research Centre for Multiple Long-Term Conditions is offering a fully funded two-year postdoctoral position in collaboration with Kathmandu Medical College.

Overview

The National Institute for Health and Care Research has granted funding to the Kathmandu Medical College Public Limited, Public Health Foundation of India, and the University of Leicester for the establishment of a Global Health Research Centre focusing on Multiple Long-Term Conditions (MLTCs). The Centre’s efforts aim to transform healthcare delivery, offering a more comprehensive approach to managing MLTCs and enhancing the overall well-being of affected individuals in Nepal and beyond.

The fully funded two-year postdoctoral position will be embedded within the Centre, and the selected candidates will work full-time with the Centre investigators with joint mentoring from KMC Nepal and the University of Leicester to conduct research. This may include (but is not limited to) formative research to develop the intervention, health system assessments, designing and implementing pilot cluster randomized controlled trial, full-scale cluster RCT, process evaluation of the trial, participatory action research, etc.  

Skills and Competencies

  • Highly motivated with an eye for details
  • Strong technical skills with the breadth of knowledge and some in-depth understanding of the area to be explored
  • Proficient (or willingness to build skill) in using software for quantitative (Stata or R), qualitative (NVivo), and mixed methods analysis  
  • Track record of high-quality research (e.g., at least two publications in peer-reviewed journals or similar to PhD)
  • Excellent verbal and written communication skills in English and one local language where the work will be done
  • Willingness and ability to work with teams and individually  

Experience

  • At least one year of experience after PhD (if applicable), or two years after MD, preferably in health/development projects.

Employment Type: Post Doc

Salary: Paid Fellowship

Required Documents

  • CV or Bio-Sketch, PhD/Masters Certificate, Statement of purpose (max 2-pages), Two publications (if available where the candidate is the first author, Name, address, and email ID of two references.

How to Apply

Please email the above-mentioned documents as one single PDF to mltc_centre @ kmc.edu.np before April 30, 2025.

Official Info (Linkedin)

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
WHO consolidated guidelines on tuberculosis: module 3: diagnosis
Communicable DiseasesInternational Plan, Policy & GuidelinesPublic HealthPublic Health Update

WHO consolidated guidelines on tuberculosis: module 3: diagnosis

by Public Health Update
written by Public Health Update

To support countries and technical agencies in their efforts to strengthen detection of tuberculosis (TB), the World Health Organization (WHO) published the WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis today. When compared with the previous edition issued in 2024, this guideline is the first to:

  • Combine the WHO policy guidance on diagnosis of TB infection, disease and drug resistance into a single reference document
  • Present new recommendations on concurrent testing of respiratory and non-respiratory samples among people of all ages living with HIV and children without HIV or with unknown HIV status
  • Establish two new classes of TB diagnostic technologies for the initial detection of TB and resistance to rifampicin, and
  • Outline current WHO TB diagnostic class determination and product assessment definitions and pathways.

The WHO operational handbook on tuberculosis. Module 3: Diagnosis will accompany these WHO consolidated guidelines. The WHO operational handbook provides laboratory personnel, clinicians and other clinical staff, as well as ministries of health and technical partners, detailed guidance on implementing the WHO evidence-based recommendations. Updates in the companion Handbook include consolidation of guidance on TB infection, diagnosis, and drug resistance testing, considerations for the implementation of new diagnostic classes and concurrent testing strategies, and presentation of policy statements on the use of new or updated interferon gamma release assays for the detection of TB infection, as well as targeted next generation sequencing solutions for the detection of drug-resistant TB. These class and product advances are followed by an overview of the steps and processes required to implement and scale up new tests for TB detection and revised model diagnostic algorithms that reflect the new WHO TB testing policy recommendations.

Main changes to the guidance in this update

  • Two new classes of TB diagnostic tests for the initial detection of TB and resistance to rifampicin were established; these classes differ in the level of procedure and test result automation, and include tests that were previously recommended as standalone products. The new low-complexity automated nucleic acid amplification test (LC-aNAAT) class includes the Xpert® MTB/RIF and Xpert MTB/ RIF Ultra assays, and the Truenat® MTB Plus and MTB-RIF Dx assays. The lowcomplexity manual nucleic acid amplification test (LC-mNAAT) class includes the LoopampTM MTBC Detection Kit (TB LAMP) (Eiken Chemical). These new classbased recommendations supersede previous product-specific recommendations.
  • Concurrent testing of respiratory and non-respiratory samples for the initial detection of TB and resistance to rifampicin is newly recommended for adults and adolescents living with HIV, children living with HIV, and children without HIV or with unknown HIV status.Existing guidelines on tests for TB infection were added, to consolidate policy guidance on testing for TB diagnosis, drug resistance and infection.
  • A description of TB diagnostic test determination and the pathways for TB diagnostic product prequalification by WHO was added to the Background section.
  • TB diagnostic test class description tables were revised to align with the classdetermination criteria presented in the Background section.
  • The four prior web annexes covering systematic review and guideline development group (GDG) evidence to inform policy updates were consolidated into two web annexes. Web Annex A includes the systematic reviews, Grading of Recommendations Assessment, Development and Evaluation (GRADE) tables and evidence to decision (EtD) tables, and Web Annex B includes the evidence synthesis and analysis findings. Both web annexes now present content by TB diagnostic class
0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
WHO
Global Health NewsOutbreak NewsPublic HealthPublic Health NewsPublic Health UpdateWorld News

WHO Member States conclude negotiations and make significant progress on draft pandemic agreement

by Public Health Update
written by Public Health Update

Proposal to be submitted to World Health Assembly in May for consideration.

After more than three years of intensive negotiations, WHO Member States took a major step forward in efforts to make the world safer from pandemics, by forging a draft agreement for consideration at the upcoming World Health Assembly in May. The proposal aims to strengthen global collaboration on prevention, preparedness and response to future pandemic threats.

In December 2021, at the height of the COVID-19 pandemic, WHO Member States established the Intergovernmental Negotiating Body (INB) to draft and negotiate a convention, agreement or other international instrument, under the WHO Constitution, to strengthen pandemic prevention, preparedness and response.

Following 13 formal rounds of meetings, nine of which were extended, and many informal and intersessional negotiations on various aspects of the draft agreement, the INB today finalized a proposal for the WHO Pandemic Agreement. The outcome of the INB’s work will now be presented to the Seventy-eighth World Health Assembly for its consideration.

“The nations of the world made history in Geneva today,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “In reaching consensus on the Pandemic Agreement, not only did they put in place a generational accord to make the world safer, they have also demonstrated that multilateralism is alive and well, and that in our divided world, nations can still work together to find common ground, and a shared response to shared threats. I thank WHO’s Member States, and their negotiating teams, for their foresight, commitment and tireless work. We look forward to the World Health Assembly’s consideration of the agreement and – we hope – its adoption.”

Proposals within the text developed by the INB include establishing a pathogen access and benefit sharing system; taking concrete measures on pandemic prevention, including through a One Health approach; building geographically diverse research and development capacities; facilitating the transfer of technology and related knowledge, skills and expertise for the production of pandemic-related health products; mobilizing  a skilled, trained and multidisciplinary national and global health emergency workforce; setting up a coordinating financial mechanism; taking concrete measures to strengthen preparedness, readiness and health system functions and resilience; and establishing a global supply chain and logistics network.

The proposal affirms the sovereignty of countries to address public health matters within their borders, and provides that nothing in the draft agreement shall be interpreted as providing WHO any authority to direct, order, alter or prescribe national laws or policies, or mandate States to take specific actions, such as ban or accept travellers, impose vaccination mandates or therapeutic or diagnostic measures or implement lockdowns.

Dr Tedros paid tribute to the members of the Bureau who guided the INB process: Co-Chairs Ms Precious Matsoso (South Africa) and Ambassador Anne-Claire Amprou (France), and Vice-Chairs Ambassador Tovar da Silva Nunes (Brazil), Ambassador Amr Ramadan (Egypt), Dr Viroj Tangcharoensathien (Thailand); and Ms Fleur Davies (Australia). Past members included former Co-Chair, Mr Roland Driece (the Netherlands), and former Vice-Chairs Ambassador Honsei Kozo (Japan), Mr Kazuho Taguchi (Japan), and Mr Ahmed Soliman (Egypt). The Director-General also acknowledged the constant support provided by WHO Secretariat colleagues.

INB Co-Chair Ms Matsoso said: “I am overjoyed by the coming together of countries, from all regions of the world, around a proposal to increase equity and, thereby, protect future generations from the suffering and losses we suffered during the COVID-19 pandemic. The negotiations, at times, have been difficult and protracted. But this monumental effort has been sustained by the shared understanding that viruses do not respect borders, that no one is safe from pandemics until everyone is safe, and that collective health security is an aspiration we deeply believe in and want to strengthen.”

Fellow INB Co-Chair, Ambassador Amprou, said the draft agreement is a major step in strengthening the global health security architecture so people of the world would be better protected from the next pandemic.

“In drafting this historic agreement, the countries of the world have demonstrated their shared commitment to preventing and protecting everyone, everywhere, from future pandemic threats,” Ambassador Amprou said. “While the commitment to prevention through the One Health approach is a major step forward in protecting populations, the response will be faster, more effective and more equitable. This is a historic agreement for health security, equity and international solidarity.”

The INB was established in December 2021, at a special session of the World Health Assembly, bringing together Member States and relevant stakeholders, including international organizations, private sector, and civil society. At the World Health Assembly in June 2024, governments made concrete commitments to complete negotiations on a global pandemic agreement within a year. The upcoming Assembly starting 19 May 2025 will consider the proposal developed by the INB and take the final decision on whether to adopt the instrument under Article 19 of the WHO Constitution.

WHO (16 April 2025, News release)

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Declaration of the Eleventh National Summit of Health and Population Scientists in Nepal
ConferencePublic Health Update

Declaration of the Eleventh National Summit of Health and Population Scientists in Nepal

by Public Health Update
written by Public Health Update

The 11th National Summit of Health and Population Scientists in Nepal, organized by the Nepal Health Research Council (NHRC) from 10–12 April 2025 in Kathmandu, concluded with a collective declaration to advance health research in Nepal.

With the central theme of “Health, Climate, and Population Dynamics: Building Resilient Health Systems for a Sustainable and Equitable Future.” the summit emphasized that a resilient health system is the cornerstone of achieving sustainability and equity.

The summit addressed the interconnectedness of health, climate change, and population dynamics, and highlighted the importance of interdisciplinary research to inform effective health policies and practices. Given the global challenges such as climate change, demographic shifts, emerging health threats, and persistent health disparities, the need for robust, high-quality evidence has become more urgent than ever.

In this context, the delegates of the summit collectively commit to the following six declarations:

  1. Strengthen and harmonize health research governance through revision of institutional and legislative provisions in a collaborative way in the Federal Context for promoting responsible conduct of research, and evidence-based policy formulation, planning and effective implementation
  2. Increase investment in health, population and environment research to promote quality research for evidence informed decision making.
  3. Promote human capital in health research by creating conducive environment for young researchers and retention of experienced researchers in the country.
  4. Strengthen collaboration between researchers, policy makers, academia, scientists, civil society, private sector and community to promote high-quality interdisciplinary research for effective response to existing and emerging health issues and future pandemics through use of new technologies (such as digital, AI) towards strengthening the quality of research.
  5. Promote interdisciplinary research on wider determinants of health, implementation research and clinical research using one health approach.
  6. Enhance health research capacity of researchers through regular trainings, fellowships and grants.
Declaration of the Eleventh National Summit of Health and Population Scientists in Nepal
Declaration of the Eleventh National Summit of Health and Population Scientists in Nepal
0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Course on Public Health Systems - Challenges and Opportunities: The Case of Nepal
CoursesInternational Jobs & OpportunitiesOpportunities by RegionPublic Health OpportunitiesPublic Health OpportunitySummer and Winter CoursesSummer Courses

Course on Public Health Systems – Challenges and Opportunities: The Case of Nepal

by Public Health Update
written by Public Health Update

Overview

The Center for International Health (CIHLMU) in collaboration with the Patan Academy of Health Sciences (PAHS) announces the course “Public Health Systems – Challenges and Opportunities: The Case of Nepal”, to be held from May 5–9, 2025 in Lalitpur, Nepal.

Key information

Date: May 05-09, 2025
Course Language: English
Registration Deadline: April 18, 2025
Course credits: 3 ECTS
Location: Patan Academy of Health Sciences, Nepal

Content

  • An overview of the Public Health delivery system in Nepal
  • Comparison of health care systems in different resource settings
  • Health related challenges from supply side and demand side
  • Public health interventions to address health problems
  • Socio-cultural determinants of health care seeking behaviour in Nepal.

This course has been accredited by tropEd Network for Higher Education Institutions in International Health.

Learning Objectives

At the end of the module, the participants will be able to:

  • Describe the health care delivery system in Nepal,
  • Identify major sources of health-related information,
  • Explain major health problems including challenges and opportunities to address these problems,
  • Identify socio-cultural aspects of care seeking, service delivery and health behaviors,
  • Identify innovations and initiatives to address health problems both from supply side and demand side,
  • Compare problems and challenges of health care systems in developed and developing countries, and
  • Assess and discuss possible health system solutions in a resource-constrained system.

Registration

Registration is NOW OPEN. Click here to register until April 18, 2025.

Cancellation Policy: For cancellations made before the registration deadline, a non-refundable fee of 100 EUR will be charged. For cancellations made after the registration deadline until the course start, a non-refundable fee of 300 EUR will be charged. In case of no-shows or cancellations from the start of the course, the full course fee will be charged.

Course Coordinators in Nepal

  • Sudarshan Paudel – Patan Academy of Health Sciences (Nepal)
  • Prof. Madhusudan Subedi – Patan Academy of Health Sciences (Nepal)
  • Dr. Deepak Paudel – Save the Children (Nepal)

All correspondence (inquiries, organisation and registration) via the Teaching & Training Unit in Munich, ttu@lrz.uni-muenchen.de. Click here to register until April 18, 2025.

Registration Link

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
2030 IN SIGHT LIVE Nepal 2025
ConferenceInternational Jobs & OpportunitiesPublic Health OpportunitiesPublic Health Opportunity

2030 IN SIGHT LIVE Nepal 2025

by Public Health Update
written by Public Health Update

Overview

2030 IN SIGHT LIVE is the only conference dedicated solely to uniting individuals in finding solutions to one of the world’s most critical challenges: ensuring that eye health is accessible to everyone by 2030. As International Agency for the Prevention of Blindness (IAPB)’s flagship global event, 2030 IN SIGHT LIVE gathers leaders, innovators, and changemakers to collaborate, discuss, and take decisive action on the 2030 In Sight Strategy.

The event will unite global leaders in eye health and development stakeholders under the shared purpose of shaping action for impact. Together we will confirm key policy frameworks and activate action to shape political, country, and institutional engagement, essential for ensuring the success of 2030 In Sight Strategy. As we work towards The Global Summit for Eye Health, it is our crucial opportunity to galvanize the energy, enthusiasm, and focus among the IAPB network needed to drive us toward The Summit’s goals.​

Programme aims​

  • Energised Leadership: Reignite passion and commitment among IAPB members towards the 2030 In Sight Strategy, fostering collaboration and alignment with the vision of the Global Summit on Eye Health.​ ​
  • Accelerating Progress: Facilitate collaborative development of collective action plans, share expertise and experience to address critical eye health priorities, leading to tangible outcomes.​
  • Empowered Advocacy: Equip participants with the tools and strategies to collectively champion eye health at national and international levels, fostering unified advocacy efforts for policy change and implementation.

Key Information

  • Event date: 29 April – Member Engagement Groups Day and 30 April – 1 May – 2030 IN SIGHT LIVE
  • Where: Kathmandu, Nepal
  • Venue: The Soaltee Hotel, Tahachal Marg, Kathmandu 44600, Nepal ​

For more information, please visit official IAPB announcement.

Official Info (registration)

The 2030 IN SIGHT LIVE conference is an important global event happening in Nepal. This will not only be a platform to highlight the global and country’s eye health progress and challenges at a global gathering but also an exciting opportunity for local eye health professionals to expand their networks and enhance knowledge. We encourage all Nepali eye health professionals to take advantage of this exciting opportunity and join at 2030 IN SIGHT LIVE!

Related readings
0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Global Health Norway Conference 2025 - Together for Global Health
Annual MeetingConferenceInternational Jobs & OpportunitiesOpportunities by RegionPublic Health EventsPublic Health OpportunitiesPublic Health Opportunity

Global Health Norway Conference 2025 – Together for Global Health

by Public Health Update
written by Public Health Update

Overview

The annual Global Health Norway Conference will take place on November 5–6, 2025, in Bergen. This year, the event is hosted by the Centre for International Health at the University of Bergen.

The conference is structured in two main parts; Thematic keynote sessions and scientific abstract presentations.

Programme

Part I: Thematic Keynote Sessions

The first part will feature keynote discussions around four central themes:

  • North-South Collaboration: How can we strengthen cooperation?
    Successful global partnerships between the Global North and South require mutual respect, transparent communication, and shared objectives. Recognizing the historical impacts of colonization is essential for creating fair and balanced relationships.
    Keynote Speaker: Dr. Catherine Kyobutungi, Executive Director of the African Population and Health Research Center (APHRC) and Co-Editor-in-Chief, PLOS Global Public Health.
  • Climate Change: How can we best respond to this global crisis?
    With escalating climate concerns—rising temperatures, sea level rise, and extreme weather events—how do these changes impact global health? One case study to be explored is heat-induced kidney disease.
    Keynote Speakers: Prof. Carl-Gustaf Elinder, Karolinska University Hospital and Karolinska Institutet, Sweden; Prof. Helge Drange, Geophysical Institute, University of Bergen.
  • Research Prioritization: How should we decide what matters most?
    Insights will be shared from the Global Burden of Disease project and discussions will focus on setting research priorities in global health.
    Keynote Speakers: Prof. Simon Øverland, Centre for International Health; Prof. Kjell Arne Johansson, BCEPS; Prof. Emeritus Stein Emil Vollset, University of Bergen.
  • Artificial Intelligence in Global Health: How can we harness its potential?
    AI offers transformative opportunities in global health, from improved diagnostics to personalized care and system optimization.
    Keynote Speaker: Prof. Pinar Heggernes, University of Bergen.

Part II: Scientific Abstract Presentations

Researchers, students, and health professionals are invited to submit abstracts on topics relevant to global health research. Accepted submissions will be presented during the second part of the conference.

Registration

Registration Link. There is no registration fee.

For more information about the Global Health Norway Network and conference, please visit official webpage.

0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberThreadsBlueskyEmail
Newer Posts
Older Posts
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023